Development of Obesity and Bariatric Surgery
Launched by THE AFFILIATED NANJING DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL · Sep 25, 2017
Trial Information
Current as of August 20, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Body mass index ≥18 kg/m2
- • 2. already received bariatric surgery or abdonimal surgery
- Exclusion Criteria:
- • 1. acute stroke or acute myocardial infarction in 6 months
- • 2. autoimmune disease
- • 3. long-term use of non-steroidal anti-inflammatory drugs, corticosteroids and immunosuppressive drugs
- • 4. pregnancy
- • 5. consists with other endocrine diseases
- • 6. acute infection in2 weeks
- • 7. cancer
- • 8. use of antibiotics in 3 months
- • 9. chronic digestive inflammations 9
About The Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School is a leading academic medical institution in China, renowned for its commitment to advanced healthcare, research, and medical education. As a prominent sponsor of clinical trials, the hospital leverages its state-of-the-art facilities and multidisciplinary expertise to facilitate innovative medical research aimed at improving patient outcomes. With a focus on translational medicine, the institution fosters collaborations between clinicians and researchers to accelerate the development of novel therapies and enhance the understanding of complex diseases. Through its rigorous adherence to ethical standards and regulatory compliance, the hospital is dedicated to advancing medical knowledge and contributing to the global scientific community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nanjing, Jiangsu, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials